Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ISRG on technical watch.
ISRG looks to try and break the major resisitance of the 50Dma.
The last time it broke through the 50Dma it ran to 400 in Nov.
The Dec 5th Recall of the robotic devices has not set well with investors it seems as the distribution days are again gaining momo. With the rickshaw doji, I would assume a neutral to small decline today.
The DM ADX is showing a major pinch going on with the DM in the middle. It could go either way.
It looks as the Pivot point and the 50Dma is creating a major resistance point.
The BB's are spread out nicely showing room to move if the 381 is pierced and holds.
Mornin All,
looking at GLD to Pop today, hold, then drop in the next week.
GILD has two big news stories.
First they were approved by the FDA on Friday after hours. Then at 0312hrs EST thay send out this news brief.
3:12 am Gilead Sciences announces pivotal Phase 2 data for Idelalisib in refractory indolent non-hodgkin's lymphoma (GILD) : Co announces results of a Phase 2 study evaluating idelalisib, an investigational oral inhibitor of PI3K delta, for the treatment of patients with indolent non-Hodgkin's lymphoma that is refractory to rituximab and to alkylating-agent-containing chemotherapy. In this study, single-agent treatment with idelalisib achieved an overall response rate of 57% with a median duration of response of 12.5 months.
Of the 71 patients who responded to therapy, seven (6%) achieved a complete response, 63 (50%) had a partial response and one (one%) had a minor response. Among patients who responded, the median duration of response was 12.5 months and the median time to response was 1.9 months. Median progression-free survival for all patients was 11.0 months and median overall survival was 20.3 months. 90% of patients experienced shrinkage in lymph node size.
The most common Grade =3 adverse event was diarrhea, which was reported in 16 patients (13%). Grade =3 transaminase elevations (a measure of liver function) were reported in 16 patients (13%). Of the 16 patients who had Grade =3 transaminase elevations, 14 were retreated with idelalisib and of those, 10 (71%) had no recurrence. Grade =3 neutropenia occurred in 34 patients (27%). Twenty-five patients (20%) discontinued therapy because of adverse events.
http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#gild
My GILD 77 calls Look yummy for DEC 13 2013. Cannot wait for monday.
I'm in at the 77 range for dec 13 2013 calls.
Evening Sir.
It looks like it was changed. Here is the listing.
http://www.thestreet.com/story/12126871/1/2014-fda-drug-approval-decision-calendar.html?puc=yahoo&cm_ven=YAHOO
Options Millionaires should have a one month subscription raffle to options Millionaire Site for whomever guesses the employment number and unemployment rate for tommorrow.
Mornin Sir. All's well in options hell.
Mornin All, GILD up 1.09% pre market. Tommorrow the FDA will decide on GILD and AUXL. On Watch.
AUXL on major alert.
Biotech Company Auxilium looks to be dealing with major issues that could be a dealt a knockout blow (short to medium term) to the company. Please see below.
Yesterday AUXL lossed a patent battle with Upsher- Smith labs on property rights.
http://ir.auxilium.com/phoenix.zhtml?c=142125&p=irol-newsArticle&ID=1882098&highlight=
The knock out blow could come as early as friday if the FDA does not approve Xiaflex that suppose to help treat Peyronies disease. Xiaflex is already on the market to treat Dupuytren's.
Aegis capital is pro AUXL with a buy rating upped to 33 from 31.
http://www.streetinsider.com/Analyst+Comments/Aegis+Capital+Boosts+PT+on+Auxilium+%28AUXL%29+to+%2433%3B+Xiaflex+Bear+Case+Just+Doesnt+Play+Out/8921817.html
Morgan Stanley and Brean Capital on the other hands do not expect it to be approved.
http://seekingalpha.com/article/1871521-auxilium-serious-red-flags-make-the-upcoming-fda-decision-for-xiaflex-a-high-risk
GILD on Alert. Friday GILD will get the results from the FDA for its hepatitis C Drug Sofosbuvir. With GILD In a major upward momentum and the last three days a pullback after testing 75, I see as major upward swing to 78-80 area if approved. below is a screen shot of my buy.
12/04/13 3644 Option Buy Open 15 GILD Dec 13 '13 $77 Call Limit Day 0.35 0.35 Executed.
TSLA on watch:
TSLA's Directional Movement with ADX is pinching hard at this time. The chart is showing the 145 area as major resisitance from the last time TSLA tried to rally (Nov 11th and 12th) and failed.
If TSLA breaks 145 and holds, the Directional Movement pinch could go positive giving momentum to the 160-165 area.
Thank you Sir.
Mornin, Jimmybob.
I read the same article about SHLD and it could have two meanings.
Scenario 1: Eddie is selling a stake from 55% to 48.5% to cut losses and profit from the high.
Scenario 2: Eddie sold his higher stake down to 48% to allow for the selling of Sears Canada and or more.
Watching the news for either scenario to play out.
BIDU seen as forming a triple top. If this pattern does not breakout, then watch for a retest of the 20Dma at the 159 area.
Alert:
GOOG heading back up to try and break out. Keep on watch. If it breaks, 1120 becomes the next major resistance point.
SHLD sliding hard breaking the 50Dma.
SHLD just broke pivot support. Could sit for a consolidation? watch for the break of the 50Dma for confirmation of a breakdown to the 55 level.
Could be forming a base, but PCLN needs to get the sellers out, catch its breath before it runs again. Oscillators are showing a decline with PCLN in the overbought area.
Alert.
Watch for a big dip(2%) coming to PCLN this week. Chart showing major slow down action and a top forming. If PCLN does not break the 1195 region and hold by Wednesday, PCLN could break the chart weekly Pivot point of 1175 falling as far as the 1150 region by Friday.
Afternoon All,
Looking for the Christmas flop this year. The reasoning is; the whole year has been in a major rally inverse to the corporate earnings cycle. Corporations can only buy back so many shares to keep their EPS up. 4th Q and the FED will be the buzz killers.
In my opinion, I see December starting off with the indices topping off and volatility returning with a vengeance. The second week we can look forward to cyclic stocks starting to take major hits.
I will be the bear that ate Christmas.
Evening Everyone,
GLD and SLV on alert. During the next few weeks GLD and SLV will trend into a volatile zone awaiting the Dec FED meeting outcome.
DUST will receive residual swings as GOLD retreats into bear territory going into January 2014.
My personal take is GOLD will retreat below the 1000 mark a few weeks after the FED DEC meeting.
I am staying 80% liquid awaiting the first remarks from Janet Yellen when she delivers her first speech as FED chaiman on the hill.
Just my thoughts as the information starts to show patterns.
Evening Jimmybob.
SHLD was pumped by someone or entity (do not know who). Whomever wrote and the sent the article was selling the last two days. I was watching the trades and they were skewered. Some one or entity was selling their shares and buying shorts at the same time. I agree it could go to 70 with such a small float but the odds are increasing exponentially against SHLD each day the false article shows its true colors.
SHLD classic pump with false info. WOW.
With the press release regarding Sears containing false info watch for sears to start its slow roll south and picking up speed toward 30-32 per share before EOY.
Morning everyone.
SHLD on watch for short buying then drop for the monthly.
LOL. Anything possible, all things probable.
Really???
SFLY selloff overdone. Looking at Dec 52.5 calls.
http://finance.yahoo.com/news/shutterflys-q3-loss-narrows-beats-151007834.html
ALERT-ALERT-ALERT
The DOW is in a peculiar situation. The infamous triple top. Look for increased volatility to start as soon as next week.
Major stocks to have on watch for increased volatility are:
NKE, AMZN, GOOG,CMG, BWLD, FB,SODA, LNKD, TSLA, NFLX.
Evening Everyone,
Looks like the Dollar is trying to put in a floor. If it holds today, Look for the dollar to rebound hard with GLD taking a cliff dive to 115-118 area.
$DJECOM and $DJINET ETF's are looking to pullback if the 450 and 250 area respectively is not regained and/or not broken in the coming days. These ETF's have the most exposure in stocks like AMZN, GOOG, APPL etc.
DOW $INDU looking like a Tweezer top forming with a twist. If the DOW cannot break out here in the next two days, look for a reversal set up for the Fed meeting next week.
PCLN ADX and +DI starting to pinch. Could see 1100 plus today?
FFIV looking for 105-109 in the next week. Upgrades a cometh.
MA on pop and drop watch today. Earnings call 31 Oct 13.
CMG Nov 1st 490 puts on watch. CMG Momo could run out of steam tomorrow as PNRA announces earnings tonight.
looks to me that maybe Mr. Icahn is selling his stake here. He did buy in at around 85 last year.
ALERT-ALERT-ALERT
Carl Ichahn has sold his 10% stake in WBMD on the 18th of Oct. Look for a pop that happened yesterday, then a drop coming on earning that come out on the 29th of Oct.
http://www.sec.gov/Archives/edgar/data/1414181/000114036113039115/xslF345X03/doc1.xml
TSLA on Drop Alert. TSLA weekly chart showing signs of fatigue. Could see a dramatic drop coming soon.
Moring All,
GOOG on watch. Key support held and earnings next week. Could hit 870 today.